Balasch, J <br/><br/>
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.  [electronic resource] 

 -  Journal of assisted reproduction and genetics  Oct 1998 
 - 552-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1058-0468 
<br/><br/><label>Standard No.: </label>10.1023/a:1022586221077  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anovulation--drug therapy<br/>Chorionic Gonadotropin--therapeutic use<br/>Estradiol--blood<br/>Female<br/>Follicle Stimulating Hormone--administration & dosage<br/>Humans<br/>Immunoenzyme Techniques<br/>Inhibins--blood<br/>Insemination, Artificial--physiology<br/>Ovarian Follicle--drug effects<br/>Ovulation Induction--methods<br/>Radioimmunoassay<br/>Recombinant Proteins--administration & dosage